Recommended Global Pharmaceutical Sciences Webinars & Conferences
Asia Pacific & Middle East
Cardiovascular-2025
About Conference
We proudly invite all the members and sponsors throughout the globe to attend the “5th World Congress on Cardiovascular Medicine Pharmacology” scheduled July 24-25, 2025 in Paris, France. The essential recognition and subject of the conference is “Targeting Cardiovascular Disease: Pharmacological Frontiers”. Cardiovascular Conference strives to bring renowned Cardiologists, Cardiovascular online visitors ranging from Researchers, Academicians and Business professionals, who are working in this field, students and Business delegates under a single roof providing an opportunity to share the knowledge and scientific progress in the field of Cardiovascular Medicine and Cardiac Surgery shaping the future research
Theme: "Targeting Cardiovascular Disease: Pharmacological Frontiers". Cardiovascular 2025 is centred on the significance to understand, to meet and impart the information to prominent people connected with the institutions and towards the modern information and which contains brief of feature introductions, speaker talks, Exhibition, Symposium, and Workshops. This Heart Diseases Congress, cardiovascular gatherings or rather all Cardiology meeting, cardiology occasions will help in systems association, B2B collaborating in the midst of subject matter experts and academicians. We have managed different convincing cardiology occasions and cardiology conferences and create extraordinary relations bringing the specialists and affiliations together. Cardiology meetings are vital for the fundamental individuals to ponder the most essential piece of the human body.
Why to attend
The 5th World Congress on Cardiovascular Medicine Pharmacology in Paris, France scheduled July 24-25, 2025 Paris, France. A hub for medical innovation and research. Paris attracts leading researchers and experts in cardiovascular medicine and pharmacology from around the world. This congress will likely feature presentations on the latest research findings, advancements in treatment modalities, and emerging pharmacological therapies. The congress will likely include educational sessions such as keynote speeches, panel discussions, and workshops. These sessions provide valuable insights into best practices, treatment guidelines, and practical considerations in cardiovascular pharmacology.
It's an event where you can expand your knowledge, build connections, and contribute to advancements in cardiovascular care and pharmacology.
Connect with peers, researchers, clinicians, and industry professionals from around the world. Networking opportunities allow you to build professional relationships, collaborate on research projects, and stay connected with colleagues in the field.
Sessions
Track 1:Cardiovascular Medicine
Cardiovascular Medicine is the widespread provider of cardiovascular amenities converging in the detection, management, treatment & prevention of several cardiovascular diseases. The specialty of cardiovascular medicine emphases on the diagnosis and treatment of diseases of the heart and blood vessels or the vascular system, which include: coronary artery disease, heart rhythm disorders, heart failure, congenital heart defects, heart valve disease, heart muscle disease, and disorders of the vascular system including the aorta and other vessels.
High blood pressure is otherwise known as hypertension, is a severe medical condition. When the force of the blood pumping through your arteries is too strong, it generally happens. Heart pushes blood through your arteries to the rest of your body when it beats. Your blood pressure goes up, when the blood pushes harder against the walls of your arteries. In a day your blood pressure may be different at different times. When you first wake up, after you exercise, or when you are under stress, it is usually higher. It is normal having higher blood pressure for short amounts of time. But, when your blood pressure stays high for most of the time, it can cause serious health problems.
Track 3:Devices / CRT / ICD / Surgery
To treat heart disease, implantable devices have been used for years. The 1st pacemaker was implanted over forty years ago, and implantable defibrillators were 1st used in the early 1980s. But the last few years have viewed a surge in both the varieties of devices being verified for heart-failure treatment, and in the optimism of experts about their usefulness.
The implantable cardioverter defibrillator or ICD is a microcomputer which is fixed beneath the skin of the upper chest area. It is so small that it can fit in the palm of your hand. It observers the heart rate and provides therapy in the form of small electrical pulses. The (cardiac resynchronization therapy implantable cardioverter defibrillator) used for the treatment of heart failure is a sort of particular ICD. The cardiac resynchronization therapy (CRT) heart device is not an open-heart method where medication is frequently given to make you sleepy and for being comfortable before surgery. The process is done under local anesthesia.
Cardiac surgery, also called heart surgery which involves surgical operations performed on the heart under to correct life-threatening conditions. The surgery can be either open-heart surgery or minimally invasive surgery depending on the condition to be corrected. The purpose of cardiac surgery is to improve the quality of life of the patient and to extend the patient's lifespan.
The name Angina pectoris is the medical term for chest pain or uneasiness caused by coronary heart disease. It happens while the heart muscle doesn't get as much blood as it requires. This generally occurs because one or more of the heart's arteries is narrowed or blocked, also termed as ischemia. Painful pressure, squeezing or pain in the centre of the chest is generally caused by angina. You can feel the discomfort in your neck, jaw, shoulder, back or arm too. Angina in women can be dissimilar than in men.
Open-heart surgery is any kind of surgery where the chest is cut open and surgery is done on the muscles, valves, or arteries of the heart. Coronary artery bypass grafting is common type of heart surgery which is done on adults. During this type of surgery, a healthy artery/ vein is grafted to a blocked coronary artery. This permits the grafted artery to bypass the blocked artery & bring fresh blood to the heart. Open-heart surgery is also termed as traditional heart surgery. Now days many new heart techniques can be performed with only small incisions, not wide openings.
Atrial fibrillation is an irregular heart rhythm occurred by fast and irregular beating of the atria. Often it initiates as brief episodes of abnormal beating which become longer and possibly constant over time. Often episodes have no signs; there may be heart-palpitations, lightheadedness, fainting and shortness of breath or chest pain. The disease is related with an increased risk of heart failure, dementia, and stroke. It is a type of supraventricular tachycardia.
The most common variable risk factors for atrial fibrillation are high blood pressure & valvular heart-disease. Additional heart-related risk factors comprise congenital heart disease, coronary artery disease, heart failure and cardiomyopathy. In the evolving world valvular heart disease frequently occurs as a result of rheumatic fever. Lung associated risk factors contain COPD, obesity, and sleep apnea. Other factors comprise tobacco smoking, diabetes mellitus, thyrotoxicosis and excess alcohol intake. However, half of cases are not related with any of these risks. A diagnosis is done by feeling the pulse and may be confirmed using an electrocardiogram.
Track 8:Percutaneous Cardiovascular Interventions
A non-surgical process used to treat contracting of the coronary arteries of the heart found in coronary artery disease is Percutaneous Coronary Intervention (PCI). The procedure uses coronary catheterization to visualise the blood vessels on X-ray imaging, after accessing the blood stream through the femoral or radial artery. Later, an interventional cardiologist can achieve a coronary angioplasty, by using a balloon catheter where a squashed balloon is advanced into the obstructed artery and inflated to release the narrowing; specific devices such as stents can be arranged to keep the blood vessel open. Several other processes can also be achieved. While coronary artery disease causes heart attack or chest-pain, percutaneous coronary interventions, like angioplasty only, can bring back blood-flow to the heart.
Cardio-oncology is the intersection condition of heart in patients who have been treated for cancer. Heart specialists (Cardiologists) can assess patients for potential risk of evolving heart conditions if the patient is taking specific kind of drugs for cancer or following radiation therapy to the chest. They too help oncologists defend their patients through treatment by thoroughly watching the heart and identifying heart trouble early in treatment.
Track 10:Minimally Invasive Heart Surgery
During the minimally invasive heart surgery, heart surgeons are performing surgery by making small incisions in the right-side of the chest, without any cut through the breastbone which is an alternate to open-heart surgery. They operate between the ribs, which may result lesser pain and a quicker recovery for various people. In minimally invasive surgery, the heart surgeon may have a better view of some parts of your heart than in open-heart surgery. Alike to open- heart surgery, some minimally invasive heart surgery techniques might need to stop heart temporarily & diverting blood-flow from your heart using a heart-lung bypass machine. It may be done to treat a variety of heart conditions. This surgery isn't a choice for every individual, but it can offer potential benefits in those for whom it's appropriate. The benefits include:
Track 11:Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy is a disorder which makes a portion of heart thickened without any cause by this, the heart being less able to pump blood efficiently. Symptoms differ from none to getting tired, shortness of breath, leg swelling, chest pain or fainting. It also includes heart failure, an irregular heartbeat, and sudden cardiac death. HCM is most frequently inherited from a individual's parents. It is mainly due to mutations in certain genes involved with making heart muscle proteins. Additional reasons may involve Friedreich's ataxia, certain medications such as tacrolimus & Fabry disease. It is kind of cardiomyopathy, a group of diseases that mainly affects the heart muscle. Diagnosis mostly involves an electrocardiogram, echocardiogram & stress-testing. Genetic testing may also be done. The treatment is performed by the use of beta-blockers, diuretics or disopyramide. An implantable cardiac-defibrillator may be suggested in those with specific types of irregular heart-beat. Surgery, in the form of a septal myectomy or heart transplant, may be performing in those who do not improve with other measures. With treatment, the risk of death from the disease is less than one percent a year.
Track 12:Heart Transplant Surgery
In Heart transplant surgery, cardiologists remove a person's diseased heart and replacing with a healthy heart from a deceased donor. Generally heart transplants are done on patients who have end-stage heart failure where the heart is damaged or weak. In this stage, heart can't pump enough blood to meet the body's needs. In "End-stage" the condition is so serious that all treatments, other than a heart transplant, have failed. Heart transplants are performed as a lifesaving technique for end-stage heart failure. Because donor hearts are very less, and patients who need heart transplants go through a careful selection process. The patient must be sick enough to need a new heart, yet healthy enough to receive it.
Track 13:Clinical Cases in Cardiology
Mostly, Case Studies in Cardiovascular Medicine, should detail a specific medical case, broadcasting the background of the patient. They should discuss investigations undertaken in order to determine a diagnosis or differentiate between possible diagnoses, and should indicate the type of treatment the patient underwent as a result. In one portion we can determine that Case Study is a beneficial and explanatory part of every physician's medical education.
Track 14:Interventional Cardiology
Andreas Gruentzig is known as the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter which is mainly deals with the catheter based treatment of structural heart diseases. A large number of procedures can be done on the heart by catheterization where the most frequently includes the insertion of a sheath into the femoral artery and cannulating the heart under X-ray visualization (fluoroscopy). For cannulation, the radial-artery also can be used and this method having numerous advantages which consist of the accessibility of the artery in most patients, the easy control of bleeding even in anticoagulated patients, the enhancement of relief because patients are able to sit and walk immediately following the procedure, and the near absence of clinically significant sequelae in patients with a normal Allen test. In the other side to this methodology include spasm of the artery & pain, inability to use larger-catheters required in various procedures and also more radiation exposure.
Market Analysis
Cardiovascular devices are utilized to treat cardiovascular ailments that incorporate various issues, the greater part of which are identified with atherosclerosis. Atherosclerosis is a prescription state where a substance called plaque develops in the dividers of the conduits. It contracts the veins, making it harder for blood to move through and influences the ordinary supply of blood and reasons heart assault. Heart assault happens when the blood stream of the heart is hindered by blood coagulation. Other cardiovascular illnesses, for example, ischemic stroke and heart disappointment, happen when a vein is hindered by a cluster. Moreover, heart disappointment, in some cases called congestive heart disappointment, implies that the heart is not pumping blood appropriately. Arrhythmia is additionally one of the major cardiovascular ailments, typically portrayed by a strange mood of the heart. To beat these issues, different cardiovascular devices are utilized to analyse and treat heart infections.
Larger markets for cardiovascular devices in Germany are due to increasing awareness about various heart diseases in the region and the increasing number of aged people.
Germany’s cardiovascular devices market is segmented on the basis of type (cardiac rhythm management devices, interventional cardiac devices, Automated External Defibrillators (AED), cardiac ablation catheters, cardiac pacemakers, cardiac angioplasty devices, Implantable Cardioverter Defibrillators (ICD), prosthetics (artificial) heart valves, stents, ventricular assist devices), and technology (cardiopulmonary bypass products, minimally invasive cardiac surgery, valve prosthesis & repair, cardiac assist devices).
Submit your abstract on the below topics
Visa Support
We are committed to ensuring that your participation in the Cardiovascular-2025 is as smooth and hassle-free as possible.
Our comprehensive visa support package includes:
- Official Invitation Letter: An official invitation from the conference organizers to confirm your participation. (The Official Invitation Letter will be provided once you have completed your conference registration and payment).
- Abstract Acceptance Letter: Confirmation that your abstract has been accepted for presentation at the conference.
- Payment Receipt: Proof of your registration and payment for the conference.
- Visa Covering Letter: A personalized letter outlining your purpose of visit and the details of your stay in Paris. (The Visa Support Letter will be provided once you have completed your conference registration and payment).
These essential documents will be sent to you via email in PDF format, ensuring quick and secure delivery.
We are dedicated to helping you navigate the visa application process efficiently, allowing you to focus on preparing for the conference. Should you have any questions or require additional assistance, please do not hesitate to contact us.
We look forward to welcoming you to Paris for a productive and enriching conference experience!
You can conveniently make payments through Payment Gateway/Stripe or Bank-to-Bank transfer. For any inquiries or assistance with registration and invoices, feel free to contact to cardiology@asiameets.com
Past Conference Report
Cardiovascular-2024
Past Reports Gallery cardiovascular-2023
Past Reports Gallery
To Collaborate Scientific Professionals around the World
Conference Date July 24-25, 2025
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by